The store will not work correctly when cookies are disabled.
2,2-Dimethyl-3-{4-[4-(3-methylsulfanyl-phenyl)-piperazin-1-yl]-butyl}-thiazolidin-4-one
ID: ALA131307
Chembl Id: CHEMBL131307
PubChem CID: 10834424
Max Phase: Preclinical
Molecular Formula: C20H31N3OS2
Molecular Weight: 393.62
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CSc1cccc(N2CCN(CCCCN3C(=O)CSC3(C)C)CC2)c1
Standard InChI: InChI=1S/C20H31N3OS2/c1-20(2)23(19(24)16-26-20)10-5-4-9-21-11-13-22(14-12-21)17-7-6-8-18(15-17)25-3/h6-8,15H,4-5,9-14,16H2,1-3H3
Standard InChI Key: PGGVCCGESXXUMZ-UHFFFAOYSA-N
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 393.62 | Molecular Weight (Monoisotopic): 393.1909 | AlogP: 3.62 | #Rotatable Bonds: 7 |
Polar Surface Area: 26.79 | Molecular Species: NEUTRAL | HBA: 5 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 8.12 | CX LogP: 3.10 | CX LogD: 2.30 |
Aromatic Rings: 1 | Heavy Atoms: 26 | QED Weighted: 0.52 | Np Likeness Score: -1.30 |
References
1. Hrib NJ, Jurcak JG, Bregna DE, Burgher KL, Hartman HB, Kafka S, Kerman LL, Kongsamut S, Roehr JE, Szewczak MR, Woods-Kettelberger AT, Corbett R.. (1996) Structure-activity relationships of a series of novel (piperazinylbutyl)thiazolidinone antipsychotic agents related to 3-[4-[4-(6-fluorobenzo[b]thien-3-yl)-1-piperazinyl]butyl]-2,5,5- trimethyl-4-thiazolidinone maleate., 39 (20): [PMID:8831770] [10.1021/jm960268u] |